Return to Article Details
Monitoring of chemotherapy successfulness of Platina/Taxol chemotherapy protocol by using determination of serum urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) in patients with ovarian carcinoma FIGO II
Download
Download PDF
Themes by Openjournaltheme.com
Themes by Openjournaltheme.com